메뉴 건너뛰기
Drugs
Volumn 58, Issue SUPPL. 2, 1999, Pages 383-384
Development of high level quinolone resistance in Streptococcus pneumoniae during sequential quinolone therapy
Author keywords

[No Author keywords available]
Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;
EID: 0032733738     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958002-00132     Document Type: Conference Paper
Times cited : (2)
References (4)
  • 1
    • 0014020719 scopus 로고
    • A critical evaluation of nalidixic acid in urinary tract infections
    • 1. AR Ronald M Turck RG Petersdorf 1966 A critical evaluation of nalidixic acid in urinary tract infections N Engl J Med 275 1081 9 5923022 10.1056/NEJM196611172752001 1:CAS:528:DyaF2sXpvFSg Ronald AR, Turck M, Petersdorf RG. A critical evaluation of nalidixic acid in urinary tract infections. N Engl J Med 1966; 275: 1081–9
    • (1966) N Engl J Med , vol.275 , pp. 1081-9
    • Ronald, AR1    Turck, M2    Petersdorf, RG3
  • 2
    • 0026100406 scopus 로고
    • Fluoroquinolone antimicrobial agents
    • 2. DC Hooper J Wolfson 1991 Fluoroquinolone antimicrobial agents N Engl J Med 324 384 94 1987461 10.1056/NEJM199102073240606 1:CAS:528:DyaK3MXkt1Wgurg%3D Hooper DC, Wolfson J. Fluoroquinolone antimicrobial agents. N Engl J Med 1991; 324: 384–94
    • (1991) N Engl J Med , vol.324 , pp. 384-94
    • Hooper, DC1    Wolfson, J2
  • 3
    • 0029794181 scopus 로고    scopus 로고
    • Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.
    • 3. X-S Pan J Ambler S Mehtar 1996 Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother 40 2321 6 8891138 1:CAS:528:DyaK28XmtVCgtrc%3D Pan X-S, Ambler J, Mehtar S, et al. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother 1996; 40: 2321–6
    • (1996) Antimicrob Agents Chemother , vol.40 , pp. 2321-6
    • Pan, X-S1    Ambler, J2    Mehtar, S3
  • 4
    • 0029834825 scopus 로고    scopus 로고
    • Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.
    • 4. TD Gootz R Zaniewski S Haskell 1996 Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro. Antimicrob Agents Chemother 40 2691 7 9124824 1:CAS:528:DyaK28Xnt1CmtbY%3D Gootz TD, Zaniewski R, Haskell S, et al. Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro. Antimicrob Agents Chemother 1996; 40: 2691–7
    • (1996) Antimicrob Agents Chemother , vol.40 , pp. 2691-7
    • Gootz, TD1    Zaniewski, R2    Haskell, S3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.